Titania-Supported Ni2 P/Ni Catalysts for Selective Solar-Driven CO Hydrogenation

© 2021 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 36 vom: 10. Sept., Seite e2103248
1. Verfasser: Li, Zhenhua (VerfasserIn)
Weitere Verfasser: Zhang, Xin, Liu, Jinjia, Shi, Run, Waterhouse, Geoffrey I N, Wen, Xiao-Dong, Zhang, Tierui
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article phosphidation photothermal catalysis solar-driven value-added hydrocarbons
Beschreibung
Zusammenfassung:© 2021 Wiley-VCH GmbH.
Solar-driven Fischer-Tropsch synthesis (FTS) holds great potential for the sustainable production of fuels from syngas and solar energy. However, the selectivity toward multi-carbon products (C2+ ) is often hampered by the difficulty in the regulation of transition metals acting as both light absorption units and active sites. Herein, a partial phosphidation strategy to prepare titania supported Ni2 P/Ni catalysts for photothermal FTS is demonstrated. Under Xenon lamp or concentrated sunlight irradiation, the optimized catalyst shows a C2+ selectivity of 70% at a CO conversion of >20%. Conversely, nickel metal in the absence of Ni2 P delivers negligible C2+ products (≈1%) with methane being the major product (>90%). Structural characterization and density functional theory calculation reveal that the partial phosphidation allows exposed metallic Ni to be active for CO adsorption and activation, while the existence of Ni2 P/Ni interface is responsible to inhibit CO methanation and promote C-C coupling of adsorbed *CH intermediates. This work introduces a novel phosphidation strategy for nickel-based photothermal catalysts in efficiently harnessing solar energy, and regulating the reaction pathways for CO hydrogenation to deliver high value products
Beschreibung:Date Revised 10.09.2021
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202103248